Financial Assistance
Newsletter Sign-up
Need Appointment
Contact Us
About Us

Rush University
For Physicians
For Rush Employees
For Students
Bill Payment Center
Rotate
<< Previous | New Search | Return to Search Results | Next >>

David J. Sher, MD, MPH

David J. Sher, MD, MPH
Appointment Request

Or call
(888) 352-RUSH for help arranging an appointment.
Specialty:
  • Oncology, Radiation
Board Certification:
  • Radiation Oncology
Faculty Rank: Assistant Professor
Medical or Graduate Education: Harvard Medical School
Residency: Harvard Radiation Oncology Program
Clinical Expertise:
  • Head and neck cancer
  • Lung cancer
  • Radiation therapy
  • Stereotactic body radiotherapy
Research Interests:
  • Comparative effectiveness research
  • Cost effectiveness analysis
  • Novel treatments for lung cancer
  • Novel treatments for head and neck cancer
Google Map
  • University Radiation Medicine
  • Woman's Board Center for Radiation Therapy
  • 500 S. Paulina St.
  • Ground Floor
  • Chicago, IL  60612
  • Phone: (312) 942-6817
  • Fax: (312) 942-2339
  • View Larger MapDriving Directions

Below is a list of scientific publications for which this practitioner was either the primary author or a contributor. Citations come from PubMed, a database of biomedical literature, life science journals and online books. PubMed is a service of the US Library of Medicine at the National Institutes of Health. Click on the title of the cited work for more information (this will take you directly to PubMed.gov). Listings go back five years.

  1. Cost-effectiveness of stereotactic body radiation therapy versus surgical resection for stage I non-small cell lung cancer.
    Shah A, Hahn SM, Stetson RL, Friedberg JS, Pechet TT, Sher DJ
    Cancer
    2013 Sep 1
    119(17):3123-32.
  2. Death from high-risk prostate cancer versus cardiovascular mortality with hormonal therapy: A decision analysis.
    Lester-Coll NH, Goldhaber SZ, Sher DJ, D'Amico AV.
    Cancer. 2013
    2013 Feb 7. doi: 10.1002/cncr.27980. [Epub ahead of print]
  3. Cost-effectiveness Analysis of SBRT Versus IMRT for Low-risk Prostate Cancer.
    Sher DJ, Parikh R, Mays-Jackson S, Punglia RS.
    Am J Clin Oncol. 2012
    2012 Dec 27. [Epub ahead of print]
  4. Prognostic Significance of Weight Gain During Definitive Chemoradiotherapy for Locally Advanced Non-Small-Cell Lung Cancer.
    Sher DJ, Gielda BT, Liptay MJ, Warren WH, Batus M, Fidler MJ, Garg S, Bonomi P.
    Clin Lung Cancer. 2012
    2012 Dec 20. doi:pii: S1525-7304(12)00263-X. 10.1016/j.cllc.2012.10.009. [Epub ahead of print]
  5. Predictors of IMRT and Conformal Radiotherapy Use in Head and Neck Squamous Cell Carcinoma: A SEER-Medicare Analysis.
    Sher DJ, Neville BA, Chen AB, Schrag D.
    Int J Radiat Oncol Biol Phys.
    2011 May 17
  6. Clinical Utility of 4D FDG-PET/CT Scans in Radiation Treatment Planning.
    Aristophanous M, Berbeco RI, Killoran JH, Yap JT, Sher DJ, Allen AM, Larson E, Chen AB.
    Int J Radiat Oncol Biol Phys.
    2011 Mar 4
  7. Primary radiotherapy versus radical prostatectomy for high-risk prostate cancer: A decision analysis.
    Parikh R, Sher DJ.
    Cancer.
    2011 Jun 30
    doi: 10.1002/cncr.26272
  8. Survival outcomes after radiation therapy for stage III non-small-cell lung cancer after adoption of computed tomography-based simulation.
    Chen AB, Neville BA, Sher DJ, Chen K, Schrag D.
    J Clin Oncol.
    2011 Jun 10
    29(17):2305-11
  9. Effect of respiratory trace shape on optimal treatment margin.
    Winey B, Wagar M, Ebe K, Popple R, Lingos T, Sher D, Court L.
    Med Phys
    2011 Jun
    38(6):3125-9.
  10. Cost-Effectiveness Analysis of Stereotactic Body Radiotherapy and Radiofrequency Ablation for Medically Inoperable, Early-Stage Non-Small Cell Lung Cancer.
    Sher DJ, Wee JO, Punglia RS.
    Int J Radiat Oncol Biol Phys.
    2011 Feb 10
  11. Relationship Between Radiation Treatment Time and Overall Survival After Induction Chemotherapy for Locally Advanced Head-and-Neck Carcinoma: A Subset Analysis of TAX 324.
    Sher DJ, Posner MR, Tishler RB, Sarlis NJ, Haddad RI, Holupka EJ, Devlin PM.
    Int J Radiat Oncol Biol Phys.
    2011 Feb 10
  12. Efficacy and toxicity of chemoradiotherapy using intensity-modulated radiotherapy for unknown primary of head and neck.
    Sher DJ, Balboni TA, Haddad RI, Norris CM Jr, Posner MR, Wirth LJ, Goguen LA, Annino D, Tishler RB.
    Int J Radiat Oncol Biol Phys.
    2011 Aug 1
    80(5):1405-11
  13. Treatment of Oral Cavity Squamous Cell Carcinoma with Adjuvant or Definitive Intensity-Modulated Radiation Therapy.
    Sher DJ, Thotakura V, Balboni TA, Norris CM Jr, Haddad RI, Posner MR, Lorch J, Goguen LA, Annino DJ, Tishler RB.
    Int J Radiat Oncol Biol Phys.
    2011 Apr 29
  14. Sunitinib-induced pseudoprogression after whole-brain radiotherapy for metastatic renal cell carcinoma.
    Kelly PJ, Weiss SE, Sher DJ, Perez-Atayde AR, Dal Cin P, Choueiri TK.
    J Clin Oncol.
    2010 Sep 1
    28(25):e433-5
  15. Utilizing computed tomography as a road map for designing selective and superselective neck dissection after chemoradiotherapy.
    Goguen LA, Chapuy CI, Sher DJ, Israel DA, Blinder RA, Norris CM, Tishler RB, Haddad RI, Annino DJ.
    Otolaryngol Head Neck Surg.
    2010 Sep
    143(3):367-74.
  16. Efficacy and toxicity of reirradiation using intensity-modulated radiotherapy for recurrent or second primary head and neck cancer.
    Sher DJ, Haddad RI, Norris CM Jr, Posner MR, Wirth LJ, Goguen LA, Annino D, Balboni T, Allen A, Tishler RB.
    Cancer.
    2010 Oct 15
    116(20):4761-8.
  17. Cost-effectiveness studies in radiation therapy.
    Sher DJ.
    Expert Rev Pharmacoecon Outcomes Res.
    2010 Oct
    10(5):567-82
  18. Salivary Gland Tumors Treated With Adjuvant Intensity-Modulated Radiotherapy With or Without Concurrent Chemotherapy.
    Schoenfeld JD, Sher DJ, Norris CM Jr, Haddad RI, Posner MR, Balboni TA, Tishler RB.
    Int J Radiat Oncol Biol Phys.
    2010 Nov 12
  19. Cost-effectiveness of CT and PET-CT for determining the need for adjuvant neck dissection in locally advanced head and neck cancer.
    Sher DJ, Tishler RB, Annino D, Punglia RS.
    Ann Oncol.
    2010 May
    21(5):1072-7
  20. Prognostic significance of mid- and post-ABVD PET imaging in Hodgkin's lymphoma: the importance of involved-field radiotherapy.
    Sher DJ, Mauch PM, Van Den Abbeele A, LaCasce AS, Czerminski J, Ng AK.
    Ann Oncol.
    2009 Nov
    20(11):1848-53
  21. Partial-breast irradiation versus whole-breast irradiation for early-stage breast cancer: a cost-effectiveness analysis.
    Sher DJ, Wittenberg E, Suh WW, Taghian AG, Punglia RS.
    Int J Radiat Oncol Biol Phys.
    2009 Jun 1
    74(2):440-6
  22. Absence of relationship between steroid hormone levels and prostate cancer tumor grade.
    Sher DJ, Mantzoros C, Jacobus S, Regan MM, Lee GS, Oh WK.
    Urology.
    2009 Feb
    73(2):356-61; discussion 361-2
  23. Relationship between serum adiponectin and prostate cancer grade.
    Sher DJ, Oh WK, Jacobus S, Regan MM, Lee GS, Mantzoros C.
    Prostate.
    2008 Oct 1
    68(14):1592-8.
  24. The added value of concurrently administered temozolomide versus adjuvant temozolomide alone in newly diagnosed glioblastoma.
    Sher DJ, Henson JW, Avutu B, Hochberg FH, Batchelor TT, Martuza RL, Barker FG 2nd, Loeffler JS, Chakravarti A.
    J Neurooncol.
    2008 May
    88(1):43-50
  25. Partial breast irradiation versus whole breast radiotherapy for early-stage breast cancer: a decision analysis.
    Sher DJ, Wittenberg E, Taghian AG, Bellon JR, Punglia RS.
    Int J Radiat Oncol Biol Phys.
    2008 Feb 1
    70(2):469-76
  26. Multi-institutional review of repeat irradiation of chest wall and breast for recurrent breast cancer
    Wahl AO, Rademaker A, Kiel KD, Jones EL, Marks LB, Croog V, McCormick BM, Hirsch A, Karkar A, Motwani SB, Tereffe W, Yu TK, Sher D, Silverstein J, Kachnic LA, Kesslering C, Freedman GM, Small W Jr
    Int J Radiat Oncol Biol Phys
    2008 Feb 1
    70(2):477-84
  • (If you cannot play the video, you may need to update to the latest version of Adobe Flash Player.)
  • View Transcript

Find a Doctor | Patient & Visitor Services | Health Information | Clinical Services | Events & Classes | News Room | Clinical Trials | Research at Rush
Nursing at Rush | Work at Rush | Giving to Rush | Directions to Rush | Disclaimer | Privacy Statement
For Physicians | For Rush Employees | For Students | Bill Payment Center | Site Map
© Rush University Medical Center
1653 W. Congress Parkway, Chicago, Illinois 60612